Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Angiopoietins and Tie2 in vascular inflammation
Samir M. Parikh
Current Opinion in Hematology (2017) Vol. 24, Iss. 5, pp. 432-438
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial
Michael A. Matthay, Carolyn S. Calfee, Hanjing Zhuo, et al.
The Lancet Respiratory Medicine (2018) Vol. 7, Iss. 2, pp. 154-162
Open Access | Times Cited: 514
Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS
Johnatas D. Silva, Yue Su, Carolyn S. Calfee, et al.
European Respiratory Journal (2020) Vol. 58, Iss. 1, pp. 2002978-2002978
Open Access | Times Cited: 176
Regulation and Dysregulation of Endothelial Permeability during Systemic Inflammation
Katharina E. M. Hellenthal, Laura Brabenec, Nana‐Maria Wagner
Cells (2022) Vol. 11, Iss. 12, pp. 1935-1935
Open Access | Times Cited: 103
Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients
Christopher J. Rogers, Robert J. Harman, Bruce A. Bunnell, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 107
Targeting Angiopoietin in Retinal Vascular Diseases: A Literature Review and Summary of Clinical Trials Involving Faricimab
Majid Khan, Aamir Aziz, Noah Shafi, et al.
Cells (2020) Vol. 9, Iss. 8, pp. 1869-1869
Open Access | Times Cited: 97
A unifying concept in vascular health and disease
Martin A. Schwartz, Dietmar Vestweber, Michael Simons
Science (2018) Vol. 360, Iss. 6386, pp. 270-271
Open Access | Times Cited: 86
THE ANGIOPOIETIN/TIE PATHWAY IN RETINAL VASCULAR DISEASES
Jeffrey S. Heier, Rishi P. Singh, Charles C. Wykoff, et al.
Retina (2020) Vol. 41, Iss. 1, pp. 1-19
Open Access | Times Cited: 74
Neutrophil Extracellular Traps, Angiogenesis and Cancer
Remo Poto, Leonardo Cristinziano, Luca Modestino, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 431-431
Open Access | Times Cited: 68
Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection
Ivo M.B. Francischetti, Kevin H. Toomer, Yifan Zhang, et al.
EClinicalMedicine (2021) Vol. 39, pp. 101069-101069
Open Access | Times Cited: 61
Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
Lorenzo Ferro Desideri, Carlo Enrico Traverso, Massimo Nicolò, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1413-1413
Open Access | Times Cited: 38
Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function
Cristiana Iosef, Michael J. Knauer, Michael Nicholson, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 37
Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration
Saagar A. Pandit, Bita Momenaei, Taku Wakabayashi, et al.
Ophthalmology Retina (2023) Vol. 8, Iss. 4, pp. 360-366
Closed Access | Times Cited: 26
Anti‐angiogenesis in colorectal cancer therapy
Zhenni Yang, Xuqian Zhang, Xiaozhe Bai, et al.
Cancer Science (2024) Vol. 115, Iss. 3, pp. 734-751
Open Access | Times Cited: 14
Endothelial dysfunction: Pathophysiology and therapeutic targets for sepsis-induced multiple organ dysfunction syndrome
Fei Tang, Xiaolan Zhao, Li-Yue Xu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117180-117180
Open Access | Times Cited: 14
Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19
Alec A. Schmaier, Gabriel Pajares Hurtado, Zachary Manickas-Hill, et al.
JCI Insight (2021) Vol. 6, Iss. 20
Open Access | Times Cited: 50
Lipedema: Insights into Morphology, Pathophysiology, and Challenges
Ankita Poojari, Kapil Dev, Atefeh Rabiee
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3081-3081
Open Access | Times Cited: 30
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
Xinguo Jiang, Wen Tian, Allen B. Tu, et al.
Circulation (2019) Vol. 139, Iss. 4, pp. 502-517
Open Access | Times Cited: 45
Designer high-density lipoprotein particles enhance endothelial barrier function and suppress inflammation
Yueh‐Chien Lin, Steven Swendeman, Irina S. Moreira, et al.
Science Signaling (2024) Vol. 17, Iss. 824
Open Access | Times Cited: 6
How we use angiopoietin‐2 in the diagnosis and management of vascular anomalies
Elissa Engel, Timothy D. Le Cras, Kiersten Ricci
Pediatric Blood & Cancer (2024) Vol. 71, Iss. 5
Open Access | Times Cited: 6
Tumor‐associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire
Shaivy Malik, Niti Sureka, Sana Ahuja, et al.
Cell Biology International (2024) Vol. 48, Iss. 10, pp. 1406-1449
Closed Access | Times Cited: 6
Short-term outcomes of intravitreal faricimab for refractory neovascular age-related macular degeneration
Wissam Al-Jundi, Cristian Munteanu, Berthold Seitz, et al.
Graefe s Archive for Clinical and Experimental Ophthalmology (2024) Vol. 262, Iss. 9, pp. 2867-2874
Closed Access | Times Cited: 5
Human granulosa cells function as innate immune cells executing an inflammatory reaction during ovulation: a microarray analysis
Liv La Cour Poulsen, Anne Lis Mikkelsen Englund, Marie Louise Muff Wissing, et al.
Molecular and Cellular Endocrinology (2019) Vol. 486, pp. 34-46
Closed Access | Times Cited: 40
Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS
Zhilin Li, Emilia A. Korhonen, Arianna Merlini, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 4, pp. 1977-1990
Open Access | Times Cited: 36
Fundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular Aspects
Daniella M. Mizurini, Eugênio D. Hottz, Patrı́cia T. Bozza, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 30
Angiopoietin-2 Inhibition of Thrombomodulin-Mediated Anticoagulation—A Novel Mechanism That May Contribute to Hypercoagulation in Critically Ill COVID-19 Patients
Michael Hultström, Karin Fromell, Anders Larsson, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1333-1333
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top